Once-weekly islatravir / lenacapavir combination pill maintains HIV viral suppression
|
A once-weekly single-tablet regimen containing islatravir
and lenacapavir maintained viral suppression in people with HIV who
switched from ... |
BioNTech Launches mRNA HIV Vaccine Trial
... antiretroviral therapy for at least 12 months will receive four injections. Enrollment will span participants aged 18 to 50 years; those with HIV ... View article...